Journal profile · INFECTIOUS DISEASES
Eurosurveillance
ISSN 1560-7917 · European Centre for Disease Prevention and Control (ECDC) · SWEDEN · Weekly · Founded 1995
Eurosurveillance: CAS Zone 2 · Medicine (2025 upgraded edition, Top journal); impact factor 7.97; diamond open access (no APC); no APC; review 3–8 weeks (community reports); acceptance rate 20% (journal website); 243 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Eurosurveillance is published by European Centre for Disease Prevention and Control (ECDC) and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Influenza Virus Research Studies, Respiratory viral infections research and Viral Infections and Vectors, together about 23.2% of its articles. Its main subfields are Epidemiology and Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
The article recommends continued proper use of PPE and testing of workers at outbreak sites with a risk of animal-human transmission to mitigate pandemic risk of influenza A(H5N1).
From the journal's Aims & Scope
Research area (LetPub): INFECTIOUS DISEASES
Editor-in-chief Ines SteffensPublisher website
Editorial board by country: none in mainland China; most named Sweden 6, France 3, Germany 2, Spain 2, Netherlands 2 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Influenza Virus Research StudiesMedicine9.7%
- Respiratory viral infections researchMedicine7.2%
- Viral Infections and VectorsMedicine6.3%
- Viral gastroenteritis research and epidemiologyMedicine5.6%
- COVID-19 epidemiological studiesMathematics5.4%
- Mosquito-borne diseases and controlMedicine5.1%
- Vaccine Coverage and HesitancySocial Sciences5.1%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Infectious Diseases | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPMCEmbasePublisher website
Other: Index Medicus, EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.97LetPub ·
- CiteScore 2026-06
- 13.6LetPub ·
- CiteScore (publisher)
- 13.6Publisher website ·
- SJR 2026-06
- 2.81LetPub ·
- SNIP 2026-06
- 2.24LetPub ·
- h-index
- 90LetPub ·
- h-index
- 176OpenAlex ·
- i10-index
- 3,620OpenAlex ·
- 2-year mean citedness
- 8.11OpenAlex ·
- Self-citation rate
- 3.6%LetPub ·
- Share of gold OA articles
- 97.43%LetPub ·
Volume
- Articles per year
- 188LetPub ·
Articles by year OpenAlex count · 7,078 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 171 | 171 | 180 |
| 2025 | 243 | 243 | 1,202 |
| 2024 | 272 | 272 | 4,181 |
| 2023 | 244 | 244 | 5,158 |
| 2022 | 252 | 252 | 8,810 |
| 2021 | 251 | 251 | 12,891 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Acceptance rate (publisher)
- 20%Publisher website ·
- Submission to publication (journal-reported)
- about 30 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 80 words
- Manuscript length
- ≤ 1,200 words
Article types accepted10, with length limits
- editorialsubheadings appropriate to the content. Editorial ≤ 1,500 words; ≤ 4 illustrations (figures or tables); ≤ 20 references. Mamain text ≤ 1,500 words
- perspective00 words Review Structured, ≤ 250 words Perspective Unstructured, ≤ 200 words Text – formal requirements Rapid communication ≤ 1,200 words; ≤ 4 illustrations (f…main text ≤ 1,200 words
- rapid communicationSummary table for quick reference Rapid communications Rapid communications are timely, authoritative short reports on important communicable disease findings a…main text ≤ 1,200 words · abstract ≤ 80 words · references ≤ 20
- rapid communicationsRapid communications are timely, authoritative short reports on important communicable disease findings and events where rapid dissemination of information coul…Length not stated
- regular articleSummary table for quick reference Rapid communications Rapid communications are timely, authoritative short reports on important communicable disease findings a…main text ≤ 3,500 words · abstract ≤ 250 words · references ≤ 30
- research articleSummary table for quick reference Rapid communications Rapid communications are timely, authoritative short reports on important communicable disease findings a…main text ≤ 3,500 words
- research articlesResearch articles provide original results from studies on any aspect of communicable disease epidemiology, prevention and control.Length not stated
- reviewSummary table for quick reference Rapid communications Rapid communications are timely, authoritative short reports on important communicable disease findings a…main text ≤ 4,000 words
- surveillance articlesSurveillance articles should focus on the analysis and interpretation of epidemiological trends regarding a specific disease, pathogen orLength not stated
- systematic review; ≤ 80 references.PRISMA guidelines for systematic reviews Perspective ≤ 2,000 words; ≤ 4 illustrations (figures or tables); 10–20 references. Nmain text ≤ 2,000 words
Policy excerpts from the journal's websitePublication ethics, Open access, Preprints, Self-archiving
- Publication ethics COPE Membership
Eurosurveillance is a member of the Committee on Publication Ethics (COPE). Membership indicates that the journal intends to follow the highest standards of publication ethics and to apply COPE principles of publication ethics outlined in COPE's Core Practices.
Source ↗Publisher website ·- Open access Open access and Indexing
Open access, free for readers and authors Model summary
The entire content is open access, free of charge for both readers and authors. All articles are indexed in the PubMed/MEDLINE, PubMed Central (PMC), Scopus, EMBASE, EBSCO and Science Central databases. Eurosurveillance is listed in the Directory of Open Access Journals (DOAJ) as green open access. Eurosurveillance allows pre- and postprint archiving. It is listed in the Sherpa/Romeo database as a…
Source ↗Publisher website ·- Preprints Citing preprints
Preprint and postprint archiving allowed Model summary
Preprints can be cited in submitted articles, however, the citations should be clearly labelled PREPRINT and we encourage authors to ensure that versions published after submission and before the finalisation of an article are cited where applicable. Authors should not cite their own preprint version in their submitted article, however, they should mention it in the acknowledgments section of the …
Source ↗Publisher website ·- Self-archiving
Automatic deposit in PubMedCentral Model summary
All published articles are automatically deposited in PubMedCentral.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- European Centre for Disease Prevention and Control (ECDC)
- Country or region
- SWEDEN
- Language
- English
- Frequency
- Weekly
- Founded
- 1995
- ISSN
- 1560-7917
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Eurosurveillance
What CAS zone is Eurosurveillance in?
In the 2025 upgraded edition of the CAS Journal Ranking, Eurosurveillance is in Zone 2 of Medicine, and in Zone 2 of the minor category Infectious Diseases; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Eurosurveillance?
The latest impact factor listed by LetPub is 7.97; CiteScore 13.6, h-index 176.
How long does peer review take at Eurosurveillance?
Authors report an average review time of 3–8 weeks; the journal's website gives an acceptance rate of 20%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Eurosurveillance?
According to the journal's author guidelines: Abstract: ≤ 80 words; Manuscript length: ≤ 1,200 words. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Eurosurveillance based?
Of the 41 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Sweden (6), France (3) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Eurosurveillance?
According to LetPub and DOAJ records, Eurosurveillance is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PMC and Embase; that list has not been checked against each database.
Is Eurosurveillance open access, and what is the APC?
Eurosurveillance is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .